[HTML][HTML] Discovery of a novel dual-targeting D-peptide to block CD24/Siglec-10 and PD-1/PD-L1 interaction and synergize with radiotherapy for cancer …
W Shen, P Shi, Q Dong, X Zhou, C Chen… - … for Immunotherapy of …, 2023 - ncbi.nlm.nih.gov
Background Aside from immune checkpoint inhibitors targeting programmed cell death
protein 1 (PD-1) and programmed death ligand 1 (PD-L1), intervention of CD47/Sirpα …
protein 1 (PD-1) and programmed death ligand 1 (PD-L1), intervention of CD47/Sirpα …
Discovery of a novel dual-targeting D-peptide to block CD24/Siglec-10 and PD-1/PD-L1 interaction and synergize with radiotherapy for cancer immunotherapy.
W Shen, P Shi, Q Dong, X Zhou, C Chen… - … for Immunotherapy of …, 2023 - europepmc.org
Background Aside from immune checkpoint inhibitors targeting programmed cell death
protein 1 (PD-1) and programmed death ligand 1 (PD-L1), intervention of CD47/Sirpα …
protein 1 (PD-1) and programmed death ligand 1 (PD-L1), intervention of CD47/Sirpα …
Discovery of a novel dual-targeting D-peptide to block CD24/Siglec-10 and PD-1/PD-L1 interaction and synergize with radiotherapy for cancer immunotherapy
W Shen, P Shi, Q Dong, X Zhou… - Journal for …, 2023 - search.proquest.com
Background Aside from immune checkpoint inhibitors targeting programmed cell death
protein 1 (PD-1) and programmed death ligand 1 (PD-L1), intervention of CD47/Sirpα …
protein 1 (PD-1) and programmed death ligand 1 (PD-L1), intervention of CD47/Sirpα …
[HTML][HTML] Discovery of a novel dual-targeting D-peptide to block CD24/Siglec-10 and PD-1/PD-L1 interaction and synergize with radiotherapy for cancer …
W Shen, P Shi, Q Dong, X Zhou, C Chen… - … for ImmunoTherapy of …, 2023 - jitc.bmj.com
Background Aside from immune checkpoint inhibitors targeting programmed cell death
protein 1 (PD-1) and programmed death ligand 1 (PD-L1), intervention of CD47/Sirpα …
protein 1 (PD-1) and programmed death ligand 1 (PD-L1), intervention of CD47/Sirpα …
Discovery of a novel dual-targeting D-peptide to block CD24/Siglec-10 and PD-1/PD-L1 interaction and synergize with radiotherapy for cancer immunotherapy
W Shen, P Shi, Q Dong, X Zhou… - Journal for …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Aside from immune checkpoint inhibitors targeting programmed cell death
protein 1 (PD-1) and programmed death ligand 1 (PD-L1), intervention of CD47/Sirpα …
protein 1 (PD-1) and programmed death ligand 1 (PD-L1), intervention of CD47/Sirpα …
Discovery of a novel dual-targeting D-peptide to block CD24/Siglec-10 and PD-1/PD-L1 interaction and synergize with radiotherapy for cancer immunotherapy.
W Shen, P Shi, Q Dong, X Zhou, C Chen… - … for Immunotherapy of …, 2023 - europepmc.org
Background Aside from immune checkpoint inhibitors targeting programmed cell death
protein 1 (PD-1) and programmed death ligand 1 (PD-L1), intervention of CD47/Sirpα …
protein 1 (PD-1) and programmed death ligand 1 (PD-L1), intervention of CD47/Sirpα …